Investing
Cathie Wood's ARK Invest Buys Over 240,000 Shares of Fate Therapeutics
Published:
A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a sizable purchase on Tuesday. The fund bought over 240,000 shares of Fate Therapeutics Inc. (NASDAQ: FATE) altogether, as the price of these ETFs were somewhat mixed on the day. Note that these funds are up significantly in the past year.
Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 55,163 shares of Fate Therapeutics, and ARK Innovation ETF (NYSEARCA: ARKK) bought 186,114 shares. At Tuesday’s closing price, this would have valued this purchase at roughly $20.1 million altogether. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up 50% in the past year and ARKK is up closer to 46%.
Here is a look at the other purchases across the ARK ETFs:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | ETSY | Etsy | 90,831 |
ARKF | HOOD | Robinhood Markets | 89,622 |
ARKG | SRNG | Soaring Eagle Acquisition | 214,751 |
ARKG | SMFR | Sema4 | 96,000 |
ARKG | SGFY | Signify Health | 31,587 |
ARKG | RPTX | Repare Therapeutics | 11,809 |
ARKG | MASS | 908 Devices | 46,488 |
ARKG | BEAM | Beam Therapeutics | 3,074 |
ARKG | EDIT | Editas Medicine | 35,000 |
ARKG | FATE | Fate Therapeutics | 55,163 |
ARKK | VCYT | Veracyte | 16,379 |
ARKK | PACB | Pacific Biosciences of California | 190,000 |
ARKK | FATE | Fate Therapeutics | 186,114 |
ARKK | BEAM | Beam Therapeutics | 37,694 |
ARKQ | MKFG | Markforged | 397,767 |
ARKQ | AVAV | Aerovironment | 22,232 |
ARKW | CND | Conchord Acquisition | 3,000 |
ARKW | KVSB | Khosla Ventures Acquisition II | 10,000 |
ARKW | VUZI | Vuzix | 90,000 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.